Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.34 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.34 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.34 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24772421 | 0.93 | SIRT2 (0.33) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL21736372 | 0.92 | PIM1 (0.34) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL21736046 | 0.91 | NPSR1 (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL21736044 | 0.91 | SMN1; SMN2 (0.35) | KDM4EATML3MBTL1SIRT2SIRT1 | |
| SCHEMBL21736013 | 0.89 | SMN1; SMN2 (0.35) | KDM4EATML3MBTL1SIRT2SIRT1 | |
| SCHEMBL21736583 | 0.89 | KDM4E (0.35) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL20669798 | 0.86 | PIM1 (0.36) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL21736008 | 0.85 | SMN1; SMN2 (0.32) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL21736226 | 0.83 | SIRT2 (0.32) | SIRT2SIRT1LMNASMN1; SMN2 | |
| SCHEMBL21924486 | 0.83 | PDE10A (0.33) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | PIM1 2216/4885CSNK2A2 1815/4885CSNK2B 2532/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | PIM1 2216/4885CSNK2A2 1815/4885CSNK2B 2532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.